How many clinical trials are studying AHB-137?

5 recruiting trials in our tracked data involve AHB-137.

What conditions is AHB-137 being studied for?

In our tracked recruiting trials, AHB-137 is being studied in trials for Hepatitis B, Chronic Hepatitis B, Hepatitis B, Chronic.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 5

Condition	Trials
Hepatitis B · AHB-137 for Hepatitis B	5
Chronic Hepatitis B · AHB-137 for Chronic Hepatitis B	3
Hepatitis B, Chronic	2

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
NCT07069569 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 14 locations
A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
NCT07635186 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 34 locations
A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
NCT07137910 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
NCT07370207 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
NCT07654283 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations